Search by Drug Name or NDC

    NDC 67386-0822-19 Northera 300 mg/1 Details

    Northera 300 mg/1

    Northera is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lundbeck Pharmaceuticals LLC. The primary component is DROXIDOPA.

    Product Information

    NDC 67386-0822
    Product ID 67386-822_f720e062-fafd-49bf-ab8c-ab23b25e0545
    Associated GPIs 38700030000150
    GCN Sequence Number 072025
    GCN Sequence Number Description droxidopa CAPSULE 300 MG ORAL
    HIC3 J5H
    HIC3 Description ADRENERGIC VASOPRESSOR AGENTS
    GCN 36093
    HICL Sequence Number 040936
    HICL Sequence Number Description DROXIDOPA
    Brand/Generic Brand
    Proprietary Name Northera
    Proprietary Name Suffix n/a
    Non-Proprietary Name droxidopa
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name DROXIDOPA
    Labeler Name Lundbeck Pharmaceuticals LLC
    Pharmaceutical Class Catecholamines [CS], Increased Blood Pressure [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203202
    Listing Certified Through 2025-12-31

    Package

    NDC 67386-0822-19 (67386082219)

    NDC Package Code 67386-822-19
    Billing NDC 67386082219
    Package 90 CAPSULE in 1 BOTTLE (67386-822-19)
    Marketing Start Date 2014-09-01
    NDC Exclude Flag N
    Pricing Information N/A